Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00271882 · ClinicalTrials.gov registry record
PTSD and Risk Behavior in HIV Positive Female Adolescents
A clinical trial of HIV Infections and PTSD, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 40
- Enrollment target
- 3
- Study locations
NCT00271882 is a study of HIV Infections and PTSD that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 40 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (91% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT00271882, a study of HIV Infections and PTSD, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a qualitative study using a purposive sampling methodology to interview HIV-positive female adolescents who have experienced physical and/or sexual abuse. An open-ended, in-depth interview, occurring over one to two sessions, will be conducted with each participant.
Conditions Studied
Study Locations (3)
Florida
- University of Miami - Miami
New York
- Montefiore Medical Center - The Bronx
Pennsylvania
- The Children's Hosp. of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2006-03 |
| Est. Completion | 2006-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00271882
The ClinicalTrials.gov registry entry for NCT00271882 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (91% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with HIV Infections appearing as the primary indexed condition, and to 0 interventions.
NCT00271882 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, New York, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00271882 about?
NCT00271882 is a clinical study titled "PTSD and Risk Behavior in HIV Positive Female Adolescents". This is a qualitative study using a purposive sampling methodology to interview HIV-positive female adolescents who have experienced physical and/or sexual abuse. An open-ended, in-depth interview, occurring over one to two sessions, will be conducted with each participant.
What is the current status of trial NCT00271882?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2006-03. Estimated completion is 2006-09.
What conditions does trial NCT00271882 study?
This clinical trial studies the following conditions: HIV Infections, PTSD, Sexual Abuse.
Who is sponsoring clinical trial NCT00271882?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00271882 being conducted?
This trial has 3 study locations across Florida, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
CAR-T Cells for HIV Infection
RECRUITING · Phase 1
-
A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
RECRUITING · Phase 1
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.